Prescribing of Proton Pump Inhibitors for Prevention of Upper Gastrointestinal Bleeding in US Outpatient Visits

Clin Gastroenterol Hepatol. 2024 Sep;22(9):1937-1941.e4. doi: 10.1016/j.cgh.2024.01.047. Epub 2024 Feb 15.

Abstract

Antisecretory medications, primarily proton pump inhibitors (PPIs), have proven effective in reducing upper gastrointestinal toxicities, including upper gastrointestinal bleeding (UGIB), associated with nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin, which are among the most commonly used medications in the United States.1 Accordingly, professional guidance recommends PPIs for patients at high risk for UGIB.2-4 However, little is known about trends in use of antisecretory medications for gastrointestinal prophylaxis ("gastroprotection"). Herein, we examined contemporary use and prescribing of antisecretory medications in visits by patients at high risk for UGIB, relative to visits by patients diagnosed with acid-related disorders.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Drug Utilization / statistics & numerical data
  • Female
  • Gastrointestinal Hemorrhage* / chemically induced
  • Gastrointestinal Hemorrhage* / prevention & control
  • Humans
  • Male
  • Middle Aged
  • Outpatients
  • Proton Pump Inhibitors* / adverse effects
  • Proton Pump Inhibitors* / therapeutic use
  • United States

Substances

  • Proton Pump Inhibitors